Chemotherapy-induced peripheral neuropathic pain is a major limiting factor affecting cancer patients. No effective treatment is currently...
Array
(
[id_prestablog_news] => 1068
[id_shop] => 1
[date] => 2018-12-01 00:00:00
[date_modification] => 2024-02-09 14:15:12
[langues] => ["1","2"]
[actif] => 1
[slide] => 0
[url_redirect] =>
[average_rating] =>
[number_rating] =>
[author_id] => 1
[featured] => 0
[prim_key] => 2097
[id_lang] => 1
[title] => Cinobufacini protects against paclitaxel-induced peripheral neuropathic pain and
[paragraph] => Cinobufacini protects against paclitaxel-induced peripheral neuropathic pain and suppresses TRPV1 up-regulation and spinal astrocyte activation in rats
[content] => Authors
X Ba, J Wang, S Zhou, X Luo, Y Peng, S Yang, Y Hao
Lab
School of Pharmaceutical Sciences, Health Science Center, Shenzhen University, Shenzhen, 518060, China
Journal
Biomedicine & Pharmacotherapy
Abstract
Chemotherapy-induced peripheral neuropathic pain is a major limiting factor affecting cancer patients. No effective treatment is currently available. Cinobufacini, an aqueous extract from toad skin, is a widely used anti-cancer drug in China. Clinical evidence has demonstrated the safety and effectiveness of cinobufacini in combination with chemotherapy to promote the therapeutic efficacy while alleviating side effects, especially cancer-related pain symptoms. In this study, the effects of cinobufacini were investigated in a rat model of paclitaxel-induced peripheral neuropathic pain (PIPNP) to better understand and expand its clinical application. A single injection of cinobufacini (2.5_g/kg, i.p.) alleviated pre-established PIPNP, as indicated by decreased mechanical and thermal hypersensitivity compared with paclitaxel-treated rats. Repeated cinobufacini (1.25 and 2.5_g/kg, i.p.), given during the induction of PIPNP, prevented the establishment of paclitaxel-induced mechanical and thermal hypersensitivity. This preventative effect was associated with suppressed paclitaxel-induced TRPV1 up-regulation and spinal astrocyte activation, as well as decreased production of spinal TNF-_ and IL-1_. These findings reveal cinobufacini as a therapeutic potential to treat and prevent paclitaxel-induced peripheral neuropathic pain.
BIOSEB Instruments Used
Cold Hot Plate Test (BIO-CHP)
[meta_description] =>
[meta_keywords] => https://www.sciencedirect.com/science/article/pii/S0753332218334449
[meta_title] =>
[link_rewrite] => cinobufacini-protects-against-paclitaxel-induced-peripheral-neuropathic-pain-and-suppresses-trpv1-up-regulation-and-spinal-astrocyte-activation-in-rats
[actif_langue] => 1
[read] => 1164
[count_comments] => 0
[id] => 1068
[categories] => Array
(
[90] => Array
(
[id_prestablog_categorie] => 90
[title] => Cancer
[link_rewrite] => Cancer
)
[24] => Array
(
[id_prestablog_categorie] => 24
[title] => Cross-disciplinary subjects
[link_rewrite] => Cross-disciplinary-subjects-
)
[48] => Array
(
[id_prestablog_categorie] => 48
[title] => Hot & Cold Perception
[link_rewrite] => Hot-Cold-Perception
)
[2] => Array
(
[id_prestablog_categorie] => 2
[title] => Publications
[link_rewrite] => publications
)
[13] => Array
(
[id_prestablog_categorie] => 13
[title] => Sensory system
[link_rewrite] => Sensory-system
)
)
[authors] =>
[paragraph_crop] => Cinobufacini protects against paclitaxel-induced peripheral neuropathic pain and suppresses [...]
[link_for_unique] => 1
[products_liaison] => Array
(
[563] => Array
(
[name] => Cold Hot Plate Test
[description_short] => For testing animal's thermal sensitivity to pain resulting from exposure to heat or cold: the Cold Hot Plate is an innovative instrument opening new investigation fields for your analgesia and nociception research, and a useful tool for analgesic drug screening using rats or mice models.


[thumb] =>
[img_empty] => /var/www/vhosts/de3310.ispfr.net/bioseb2024/modules/prestablog/views/img/product_link_white.jpg
[image_presente] => 1
[link] => https://bioseb.com/en/pain-thermal-allodynia-hyperalgesia/563-cold-hot-plate-test.html
)
)
)
1 Read more